Recent Press Releases
American Geriatrics Society Calls on Congress & the President to pass legislation protecting people’s access to health care across the lifespan
New York (June 28, 2022) – “The American Geriatrics Society (AGS) believes in a just society, one where we all are supported by and able to contribute to communities where ageism, ableism, classism, homophobia, racism, sexism, xenophobia, and other forms of bias and discrimination no longer impact healthcare access, quality, and outcomes for older adults and their caregivers. We condemn the Supreme Court decision in Dobbs v. Jackson Women’s Health Clinic. This ruling has significant implications for the health, well-being, and quality of life for women as well as transgender and non-binary people across the lifespan. It sets a dangerous precedent for legislative interference in the physician-patient relationship and laws have already gone into effect in multiple states that criminalize personal health decisions, limit access to health care, and penalize clinicians. We believe that this ruling will further exacerbate the inequities that exist in our health care system and that the greatest harm will be to racially and ethnically minoritized women, transgender and non-binary people, and families. We call on Congress and the administration to protect people’s access to health care and right of self-determination across the lifespan.”
- .@AmerGeriatrics opposes policies that discriminate against LGBTQ+ Individuals. http://ow.ly/rqqy50IYg5W
New York (May 3, 2022) —The American Geriatrics Society (AGS) stands against discrimination, harassment, prejudice, systemic injustice, and violence targeting any individual for their identity. We have long called for healthcare policies that require equal treatment for LGBTQ+ individuals, regardless of age, and for recognition of the preferred name and gender identity of transgender individuals, regardless of legal or biological gender status.
The AGS opposes policies that discriminate against persons who are LGBTQ+ such as the recently enacted Florida law that prohibits classroom discussion of sexual orientation or gender identity in kindergarten through third grade and laws enacted in Texas, Alabama, and Utah that discriminate against transgender individuals. We believe that legislation, orders, or policies that single out or target groups or individuals—implicitly or explicitly—impede the progress we have made, and directly stigmatize and isolate already vulnerable populations. Our members know first-hand the negative impact that a lifetime of discrimination has on the health, well-being, and quality of life of older people.
- .@AmerGeriatrics Honors Expert & Emerging #Geriatrics Leaders at #AGS22 http://ow.ly/kKat50IVGOz
New York (April 29, 2022)—The American Geriatrics Society (AGS) annually honors researchers, clinicians, educators, and emerging health professionals who have made outstanding contributions to high-quality, person-centered care for older people. This year’s award recipients include more than 20 leaders representing the breadth of disciplines championing care for us all as we age.
- Anil Makam, MD, MAS (University of California, San Francisco)
- Lee A. Lindquist, MD, MPH, MBA (Northwestern University)
- Dallas Mindo-Panusis (University of California, San Francisco)
- More than $1 million from the NIA will support the development of a new @AmerGeriatrics curriculum supporting researchers focused on older adults & multiple chronic conditions; and a series of scientific conferences focused on the concept of resilience. http://ow.ly/HTCC50GnNwH
- .@AmerGeriatrics commends the @US_FDA for authorizing 2 #COVID19 vaccines & expresses its support for the @CDCgov #ACIP's recommendations on groups that should be prioritized for #vaccination in the U.S. https://bit.ly/3h6CiiG
New York (Dec. 21, 2020) —The American Geriatrics Society today commends the U.S. Food and Drug Administration for its speedy, but thorough and transparent emergency use authorization of two COVID-19 vaccines and expresses its support for the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendations on groups that should be prioritized for vaccination in the initial phases of the U.S. COVID-19 vaccination program.
“An independent expert advisory board, FDA officials, and members of the ACIP have now vetted the available data for both the Pfizer and Moderna vaccines, and the AGS trusts the science behind them. We are happy to note that adults ages 65 and older comprised at least 21 percent of participants in Phase 3 clinical trials, and both vaccines demonstrated at least 86.5 percent efficacy in that age group,” said AGS President Annette Medina-Walpole, MD, AGSF. “Based on these results, we encourage older adults to get vaccinated when the vaccine becomes available to them.”